Analytical Data
-
基因名
A2LD1
- Application
-
别名
GGACT;A2LD1;gamma-glutamyl cyclotransferase;GGACT;EC 4.3.2.8
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BVM4
-
表达区间
1-153aa
-
氨基酸序列
MALVFVYGTL KRGQPNHRVL RDGAHGSAAF RARGRTLEPY PLVIAGEHNI PWLLHLPGSG RLVEGEVYAV DERMLRFLDD FESCPALYQR TVLRVQLLED RAPGAEEPPA PTAVQCFVYS RATFPPEWAQ LPHHDSYDSE GPHGLRYNPR ENR
-
分子量
19 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
A2LD1 is a member of the A2-like superfamily of proteins, which has garnered attention due to its potential role in various biological processes, including immune response and cellular signaling pathways. Research indicates that A2LD1 may play a crucial role in the regulation of inflammatory responses and may be implicated in several diseases, including autoimmune disorders and cancer. The protein’s structure and function are not yet fully understood, making it a prime target for further investigation. Advances in recombinant DNA technology have enabled researchers to produce A2LD1 in vitro, allowing for detailed studies of its biochemical properties, interactions, and potential therapeutic applications. By elucidating the mechanisms by which A2LD1 operates, scientists hope to uncover new insights into its role in health and disease, potentially leading to novel treatment strategies. The study of A2LD1 is particularly relevant given the increasing need for targeted therapeutic approaches in precision medicine, as well as the ongoing search for biomolecules that can modulate immune responses effectively. Continued research into A2LD1 and its recombinant forms will not only enhance our understanding of this protein but also contribute to broader efforts in drug discovery and the development of innovative treatments for various health conditions.












